PNC Financial Services Group’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.78K Sell
1,552
-860
-36% -$3.65K ﹤0.01% 4291
2025
Q4
$8.71K Sell
2,412
-469
-16% -$2.04K ﹤0.01% 4019
2025
Q3
$10.9K Buy
2,881
+1,192
+71% +$4.6K ﹤0.01% 3904
2025
Q2
$6.54K Buy
1,689
+147
+10% +$796 ﹤0.01% 4034
2025
Q1
$7.71K Hold
1,542
﹤0.01% 3920
2024
Q4
$11.1K Hold
1,542
﹤0.01% 3761
2024
Q3
$9.47K Sell
1,542
-451
-23% -$3.06K ﹤0.01% 3818
2024
Q2
$13.3K Sell
1,993
-216
-10% -$1.59K ﹤0.01% 3663
2024
Q1
$22.5K Buy
2,209
+295
+15% +$3K ﹤0.01% 3393
2023
Q4
$21.5K Buy
1,914
+1,542
+415% +$6.44K ﹤0.01% 3390
2023
Q3
$967 Sell
372
-1,102
-75% -$3.16K ﹤0.01% 4381
2023
Q2
$5.2K Hold
1,474
﹤0.01% 4102
2023
Q1
$6.22K Buy
1,474
+1,102
+296% +$13.1K ﹤0.01% 3969
2022
Q4
$6.12K Hold
372
﹤0.01% 3929
2022
Q3
$5K Hold
372
﹤0.01% 3954
2022
Q2
$4K Hold
372
﹤0.01% 4028
2022
Q1
$2K Hold
372
﹤0.01% 4165
2021
Q4
$3K Sell
372
-560
-60% -$5.95K ﹤0.01% 4058
2021
Q3
$10K Buy
932
+65
+7% +$790 ﹤0.01% 3733
2021
Q2
$9K Buy
867
+495
+133% +$6.77K ﹤0.01% 3725
2021
Q1
$5K Hold
372
﹤0.01% 3806
2020
Q4
$4K Buy
+372
New +$4.38K ﹤0.01% 3735

Other funds holding ALT

PNC Financial Services Group's ALT Position: Q1 2026 in Review

PNC Financial Services Group reduced its Altimmune (ALT) stake by 36% in Q1 2026, selling an estimated $3.65K and leaving 1,552 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #4291.

PNC Financial Services Group first reported a position in ALT in Q4 2020 and has held it in 22 quarters since. The position peaked at $22.5K in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • PNC Financial Services Group held 1,552 shares of Altimmune worth $4.78K as of Q1 2026.
  • PNC Financial Services Group sold 860 Altimmune shares in Q1 2026, an estimated $3.65K.
  • Altimmune made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4291 holding.
  • PNC Financial Services Group first reported a position in Altimmune in Q4 2020 and has held it in 22 quarters since.
  • PNC Financial Services Group's Altimmune position peaked at $22.5K in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.